CB2R agonists in clinics: a treasure chest for treating inflammatory diseases
Researchers give an update on clinical trials with CB2R agonists and their potential for the treatment of inflammatory diseases Activation of cannabinoid receptor type 2 (CB2R) has great potential for the treatment of diseases with an inflammatory component. This G protein-coupled receptor (GPCR) is a key element of the endocannabinoid system (ECS), an important lipid … Read more